VEA
VRTX icon

Virtus ETF Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-753
Closed -$303K 666
2024
Q4
$303K Sell
753
-1,723
-70% -$694K 0.12% 244
2024
Q3
$1.15M Sell
2,476
-310
-11% -$144K 0.54% 10
2024
Q2
$1.31M Buy
2,786
+129
+5% +$60.5K 0.64% 4
2024
Q1
$1.11M Buy
2,657
+264
+11% +$110K 0.59% 7
2023
Q4
$974K Sell
2,393
-562
-19% -$229K 0.62% 1
2023
Q3
$1.03M Sell
2,955
-400
-12% -$139K 0.62% 4
2023
Q2
$1.18M Sell
3,355
-477
-12% -$168K 0.7% 2
2023
Q1
$1.21M Buy
3,832
+291
+8% +$91.7K 0.66% 3
2022
Q4
$1.02M Buy
3,541
+195
+6% +$56.3K 0.53% 6
2022
Q3
$969K Sell
3,346
-260
-7% -$75.3K 0.39% 86
2022
Q2
$1.02M Buy
3,606
+1,828
+103% +$516K 0.38% 86
2022
Q1
$464K Hold
1,778
0.21% 133
2021
Q4
$390K Sell
1,778
-572
-24% -$125K 0.15% 159
2021
Q3
$426K Sell
2,350
-213
-8% -$38.6K 0.19% 163
2021
Q2
$517K Sell
2,563
-176
-6% -$35.5K 0.21% 138
2021
Q1
$589K Buy
2,739
+71
+3% +$15.3K 0.25% 128
2020
Q4
$631K Buy
2,668
+492
+23% +$116K 0.26% 99
2020
Q3
$592K Sell
2,176
-3
-0.1% -$816 0.31% 115
2020
Q2
$633K Sell
2,179
-502
-19% -$146K 0.3% 102
2020
Q1
$638K Sell
2,681
-227
-8% -$54K 0.26% 144
2019
Q4
$637K Sell
2,908
-1,160
-29% -$254K 0.1% 173
2019
Q3
$689K Sell
4,068
-688
-14% -$117K 0.14% 165
2019
Q2
$872K Buy
4,756
+329
+7% +$60.3K 0.18% 162
2019
Q1
$814K Buy
4,427
+892
+25% +$164K 1.73% 17
2018
Q4
$586K Sell
3,535
-1,516
-30% -$251K 0.1% 51
2018
Q3
$974K Buy
5,051
+340
+7% +$65.6K 0.1% 50
2018
Q2
$801K Sell
4,711
-1,623
-26% -$276K 0.71% 25
2018
Q1
$1.03M Sell
6,334
-484
-7% -$78.9K 0.9% 37
2017
Q4
$1.02M Sell
6,818
-1,482
-18% -$222K 1.28% 14
2017
Q3
$1.26M Hold
8,300
0.17% 47
2017
Q2
$1.07M Sell
8,300
-4,918
-37% -$634K 0.16% 57
2017
Q1
$1.45M Buy
13,218
+1,271
+11% +$139K 0.26% 41
2016
Q4
$880K Buy
11,947
+5,133
+75% +$378K 0.26% 75
2016
Q3
$594K Buy
6,814
+859
+14% +$74.9K 0.29% 62
2016
Q2
$512K Buy
5,955
+922
+18% +$79.3K 0.38% 57
2016
Q1
$400K Buy
+5,033
New +$400K 0.55% 50